Skip to main content

Guttmacher Institute

Donate Now

Highlights

  • Roe v. Wade in Peril
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Good reproductive health policy starts with credible research

 

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email
Guttmacher Institute

Good reproductive health policy starts with credible research

 

Donate Now

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email

Highlights

  • Roe v. Wade in Peril
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Global

HIV & STIs

The Guttmacher Institute’s international work on HIV and other STIs focuses on developing regions. Our research and advocacy efforts have focused on the linkages between HIV and sexual and reproductive health and rights, the impact of STIs on maternal and newborn health, the need for new technologies (including multipurpose prevention technologies) and U.S. support for global AIDS programs. 

  • Fact Sheet

    Investing in Sexual and Reproductive Health in Low- and Middle-Income Countries

  • Policy Analysis

    The COVID-19 Outbreak: Potential Fallout for Sexual and Reproductive Health and Rights

  • Policy Analysis

    Just $10 Per Person a Year Could Provide Sexual and Reproductive Health Services to All—Will the United States Help Make That Happen?

Top Facts & Statistics

  • 1.5M

    women living with HIV become pregnant each year worldwide
  • $10.60

    the annual per-person cost in LMICs to meet the need for essential sexual and reproductive health services
  • 1 in 3

    pregnant women in the developing world living with HIV receive no antiretroviral medication

Resources

  • March 2021 Fact Sheet

    Sexual and Reproductive Health Investment Needs in the African Union

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • March 2021 Fact Sheet

    Avantages de l’investissement dans le traitement des IST curables dans l’Union africaine

    Global

    • HIV & STIs
  • March 2021 Fact Sheet

    Avantages de l’investissement dans les services de contraception dans l’Union africaine

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • March 2021 Fact Sheet

    Avantages de l’investissement dans les soins maternels et néonatals dans l’Union africaine

    Global

    • HIV & STIs
    • Pregnancy
  • March 2021 Fact Sheet

    Avantages de l’investissement dans la santé sexuelle et reproductive dans l’Union africaine

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • March 2021 Report

    Adding It Up: Investing in the Sexual and Reproductive Health of Adolescents in India

    Rachel Murro, Rhea Chawla, Souvik Pyne, Shruti Venkatesh and Elizabeth A. Sully

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • March 2021 Fact Sheet

    Investing in Treatment for Curable STIs in the African Union

    Global

    • HIV & STIs
  • March 2021 Fact Sheet

    Investing in Contraceptive Services in the African Union

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • March 2021 Fact Sheet

    Investing in Maternal and Newborn Care in the African Union

    Global

    • HIV & STIs
    • Pregnancy
  • March 2021 News Release

    APHRC and Guttmacher Institute announce partnership to advance sexual and reproductive health and rights in Sub-Saharan Africa

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »
Explore the Data Center

Hear From An Expert

Several studies have suggested that progestin-only injectable contraceptives (particularly DMPA), may potentially increase women’s risk of HIV acquisition, but overall, the evidence is mixed and difficult to interpret. In collaboration with the World Health Organization, the Centers for Disease Control, and other partners, Guttmacher is leading an effort to systematically collect, assess and synthesize the epidemiological evidence on this important subject, to help ensure that global contraceptive guidance is informed by high-quality, up-to-date scientific information. Providing accurate information about the risks and benefits of various contraceptive options is critical, and empowers people to make more informed family planning decisions

Chelsea Polis

Principal Research Scientist

Select a country profile

Guttmacher Institute
Reproductive rights are under attack. Will you help us fight back with facts?
Donate Now
Follow Guttmacher:

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Footer Menu

  • Privacy Policy
© 2022 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.

Get Our Updates